Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity
Clinical trial NCT05089045 · COMPLETED
Trial details
- NCT number
- NCT05089045
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2021-09-16
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.